About this trial
Modern anesthesiology, in search of alternatives to opioid-based pain management, is turning to low-opioid and non-opioid protocols. Replacing opioids with non-opioid analgesics, co-analgesics, and regional and local anesthesia techniques allows avoiding the adverse effects of opioids while maintaining satisfactory analgesia. This is of particular importance in bariatric surgery, where reducing the incidence of respiratory depression, sedation, opioid hyperalgesia, and postoperative nausea and vomiting is a priority. Standard non-opioid anesthesia (OFA) includes ketamine, lidocaine, and dexmedetomidine infusions, while regional techniques additionally reduce the need for analgesics. Despite the widespread use of these methods, there is no clear data on the superiority of any of them in bariatric procedures.
Eligibility criteria
Qualifiers
Patients over 18 years who underwent laparoscopic bariatric surgery
Must be able to sign agreement for study
Disqualifiers
Patients with a history of allergic reactions to drugs
Patients with a history of drug addiction
Patients with chronic pain who require analgesics
History of hospitalization for psychiatric disorders
Trial design
Treatments tested in this trial
- Celiac Plexus Block
- ESP block
- Lidacaine